ACER THERAPEUTICS INC. Proceeds from Stock Options Exercised
ACER THERAPEUTICS INC. reported Proceeds from Stock Options Exercised of $92.27 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2021-03-01
- ACER THERAPEUTICS INC. proceeds from stock options exercised for the quarter ending 2019-12-31 was $0.00.
- ACER THERAPEUTICS INC. proceeds from stock options exercised for the quarter ending 2019-09-30 was $0.00.
- ACER THERAPEUTICS INC. proceeds from stock options exercised for fiscal 2019 was $92.27K, a 5.26% increase from fiscal 2018.
- ACER THERAPEUTICS INC. proceeds from stock options exercised for fiscal 2018 was $87.66K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $92.27K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $92.27K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $92.27K 10-Q · filed 2020-08-13 | |||
| 2018-12-31 | $87.66K 10-K · filed 2020-03-18 |